# Novagold Resources Inc: financial statements, quarterly

NG · NYSE · CIK 1173420 · [Materials](/sectors/materials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/ng.md) · [Financials](/companies/ng/financials.md) · [Filings](/companies/ng/filings.md) · [Insiders](/companies/ng/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ng/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [0.0](/filings/0001171843-24-001819.md) | [0.0](/filings/0001171843-24-003662.md) | [0.0](/filings/0001171843-24-005458.md) | not reported | [0.0](/filings/0001171843-25-001907.md) | [0.0 d](/filings/0001171843-25-004095.md) | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001171843-26-006530.md) |
| Operating income | $m | [(7.9) d](/filings/0001171843-26-000374.md) | [(9.2)](/filings/0001171843-25-001907.md) | [(11.6)](/filings/0001171843-25-004095.md) | [(7.9)](/filings/0001171843-25-006209.md) | [(9.1) d](/filings/0001171843-26-000374.md) | [(7.1)](/filings/0001171843-26-002142.md) | [(12.3)](/filings/0001171843-26-004279.md) | [(13.7)](/filings/0001171843-26-006530.md) | [(14.2) d](/filings/0001171843-26-000374.md) | [(14.9)](/filings/0001171843-26-002142.md) | [(25.8)](/filings/0001171843-26-004279.md) | [(36.0)](/filings/0001171843-26-006530.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.0) d](/filings/0001171843-26-000374.md) | [0.1](/filings/0001171843-25-001907.md) | [0.6](/filings/0001171843-25-004095.md) | [0.2](/filings/0001171843-25-006209.md) | [(0.1) d](/filings/0001171843-26-000374.md) | [0.0](/filings/0001171843-25-001907.md) | [0.0](/filings/0001171843-25-004095.md) | [0.0](/filings/0001171843-25-006209.md) | [0.0 d](/filings/0001171843-26-000374.md) | not reported | not reported | not reported |
| Net income | $m | [(10.4) d](/filings/0001171843-26-000374.md) | [(10.3)](/filings/0001171843-25-006209.md) | [(13.7)](/filings/0001171843-25-006209.md) | [(10.7)](/filings/0001171843-25-006209.md) | [(10.9) d](/filings/0001171843-26-000374.md) | [(9.1)](/filings/0001171843-26-006530.md) | [(54.3)](/filings/0001171843-26-006530.md) | [(15.6)](/filings/0001171843-26-006530.md) | [(15.6) d](/filings/0001171843-26-000374.md) | [(15.4)](/filings/0001171843-26-006530.md) | [(25.5)](/filings/0001171843-26-006530.md) | [(36.0)](/filings/0001171843-26-006530.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | [(0.03)](/filings/0001171843-25-001907.md) | [(0.04)](/filings/0001171843-25-004095.md) | [(0.03)](/filings/0001171843-25-006209.md) | not reported | [(0.03)](/filings/0001171843-26-002142.md) | [(0.15)](/filings/0001171843-26-004279.md) | [(40.00)](/filings/0001171843-26-006530.md) | not reported | [(0.04)](/filings/0001171843-26-002142.md) | [(0.06)](/filings/0001171843-26-004279.md) | [(80.00)](/filings/0001171843-26-006530.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [45.7](/filings/0001171843-25-000387.md) | [37.5](/filings/0001171843-24-001819.md) | [52.6](/filings/0001171843-24-003662.md) | [45.6](/filings/0001171843-24-005458.md) | [42.2](/filings/0001171843-26-000374.md) | [34.0](/filings/0001171843-25-001907.md) | [294](/filings/0001171843-25-004095.md) | [58.2](/filings/0001171843-25-006209.md) | [110](/filings/0001171843-26-006530.md) | [117](/filings/0001171843-26-002142.md) | [78.2](/filings/0001171843-26-004279.md) | [146](/filings/0001171843-26-006530.md) |
| Current assets | $m | [127](/filings/0001171843-25-000387.md) | [120](/filings/0001171843-24-001819.md) | [114](/filings/0001171843-24-003662.md) | [107](/filings/0001171843-24-005458.md) | [103](/filings/0001171843-26-000374.md) | [94.6](/filings/0001171843-25-001907.md) | [321](/filings/0001171843-25-004095.md) | [126](/filings/0001171843-25-006209.md) | [117](/filings/0001171843-26-006530.md) | [396](/filings/0001171843-26-002142.md) | [376](/filings/0001171843-26-004279.md) | [350](/filings/0001171843-26-006530.md) |
| Total assets | $m | [133](/filings/0001171843-25-000387.md) | [127](/filings/0001171843-24-001819.md) | [122](/filings/0001171843-24-003662.md) | [115](/filings/0001171843-24-005458.md) | [110](/filings/0001171843-26-000374.md) | [102](/filings/0001171843-25-001907.md) | [329](/filings/0001171843-25-004095.md) | [345](/filings/0001171843-25-006209.md) | [336](/filings/0001171843-26-006530.md) | [619](/filings/0001171843-26-002142.md) | [599](/filings/0001171843-26-004279.md) | [573](/filings/0001171843-26-006530.md) |
| Current liabilities | $m | [3.9](/filings/0001171843-25-000387.md) | [1.8](/filings/0001171843-24-001819.md) | [3.9](/filings/0001171843-24-003662.md) | [3.6](/filings/0001171843-24-005458.md) | [4.5](/filings/0001171843-26-000374.md) | [2.0](/filings/0001171843-25-001907.md) | [4.2](/filings/0001171843-25-004095.md) | [4.7](/filings/0001171843-25-006209.md) | [4.9](/filings/0001171843-26-006530.md) | [4.5](/filings/0001171843-26-002142.md) | [3.3](/filings/0001171843-26-004279.md) | [7.9](/filings/0001171843-26-006530.md) |
| Total liabilities | $m | [142](/filings/0001171843-25-000387.md) | [143](/filings/0001171843-24-001819.md) | [149](/filings/0001171843-24-003662.md) | [153](/filings/0001171843-24-005458.md) | [157](/filings/0001171843-26-000374.md) | [158](/filings/0001171843-25-001907.md) | [164](/filings/0001171843-25-004095.md) | [168](/filings/0001171843-25-006209.md) | [172](/filings/0001171843-26-006530.md) | [175](/filings/0001171843-26-002142.md) | [178](/filings/0001171843-26-004279.md) | [186](/filings/0001171843-26-006530.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(8.2)](/filings/0001171843-26-000374.md) | [(16.1)](/filings/0001171843-25-006209.md) | [(27.5)](/filings/0001171843-25-006209.md) | [(37.8)](/filings/0001171843-25-006209.md) | [(47.4)](/filings/0001171843-26-006530.md) | [(56.1)](/filings/0001171843-26-006530.md) | [165](/filings/0001171843-26-006530.md) | [177](/filings/0001171843-26-006530.md) | [164](/filings/0001171843-26-006530.md) | [444](/filings/0001171843-26-006530.md) | [421](/filings/0001171843-26-006530.md) | [387](/filings/0001171843-26-006530.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-02-29) | Q2 FY2024 (2024-05-31) | Q3 FY2024 (2024-08-31) | Q4 FY2024 (2024-11-30) | Q1 FY2025 (2025-02-28) | Q2 FY2025 (2025-05-31) | Q3 FY2025 (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,821) d](/filings/0001171843-26-000374.md) | [(5,374)](/filings/0001171843-25-001907.md) | [(1,196)](/filings/0001171843-25-004095.md) | [(4,039)](/filings/0001171843-25-006209.md) | [(2,033) d](/filings/0001171843-26-000374.md) | [(5,460)](/filings/0001171843-26-002142.md) | [(1,629)](/filings/0001171843-26-004279.md) | [(903)](/filings/0001171843-26-006530.md) | [(6,036) d](/filings/0001171843-26-000374.md) | [(5,262)](/filings/0001171843-26-002142.md) | [(6,401)](/filings/0001171843-26-004279.md) | [(3,261)](/filings/0001171843-26-006530.md) |
| Capital expenditure | $k | not reported | not reported | [0.0](/filings/0001171843-24-003662.md) | [0.0](/filings/0001171843-24-005458.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Shares outstanding: 438,815,994 at 2026-10-02, from the cover of the [10-Q filed 2026-10-08](/filings/0001171843-26-006530.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.